1-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)-3-oxo-7,10,13,16-tetraoxa-4-azanonadecan-19-oic acid, 98%, 1g

2-(2,3-Dimethylphenyl)-2-[4-(4-fluorophenyl)piperazin-1-yl]acetic acid, 1g

Analytical and precision scale Entris® II series Models with internal adjustment, not certified, 0.01 g, 1200 g, BCE1202i-1S

5-Fluoro-3-methylpyridin-2-ylamine, 95.0%, 25g

2,3-dimethyl-3'-methoxybenzophenone, 97.0%, 1g

2-Hexyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 5g

N-Lauroyl-L-alanine, 97%, 25g

2-(Methylsulfonyl)ethanol, 97.00%, 25g

Octadecanedioic acid mono-tert-butyl ester, 95.0%, 100g

5-(Trifluoromethyl)-2-thiophenecarboxylic acid, 98.0%, 5g

4-Fluoro-3-methyl-5-(trifluoromethyl)benzyl bromide, 10g

2-(piperidin-3-ylmethoxy)pyrazine, 95.0%, 250mg

N-(5-(3-(7-(3-FLUOROPHENYL)-3H-IMIDAZO[4,5-C]PYRIDIN-2-YL)-1H-INDAZOL-5-YL)PYRIDIN-3-YL)-3-METHYLBUTANAMIDE, 95%, 100mg